Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in TAZ-expressing early breast cancer
NCT02416427Phase 2Unknown
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of atorvastatin in breast cancer, sponsored by IRCCS Regina Elena National Cancer Institute. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02416427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416427.